Re-Excision After Positive Margins in Breast-Conserving Surgery: Can a Risk-Based Strategy Avoid Unnecessary Surgery?
Authors:
- Sabatino D’archiSabatino D’archi
- Beatrice CarnassaleBCBeatrice Carnassale
- Cristina AccettaCACristina Accetta
- Flavia De LauretisFlavia De Lauretis
- Enrico Di GuglielmoEGEnrico Di Guglielmo
- Alba Di LeoneAlba Di Leone
- Antonio FrancoAFAntonio Franco
- Federica GagliardiFGFederica Gagliardi
- Stefano MagnoStefano Magno
- Francesca MoschellaFMFrancesca Moschella
- Maria NataleMaria Natale
- Eleonora PetrazzuoloEPEleonora Petrazzuolo
Open Access
- 18 August 2025
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (16) , 5839
Abstract
Background: Re-excision after breast-conserving surgery (BCS) is routinely recommended when positive margins are found. However, secondary surgery often reveals no residual disease, exposing patients to unnecessary interventions that compromise cosmetic outcomes, increase costs, and reduce quality of life. This study investigates clinicopathological predictors of a residual tumour to identify low-risk patients who may safely avoid re-excision. Methods: We conducted a retrospective cohort study of 135 patients who underwent reoperation for positive margins following BCS at the Breast Unit of Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, between 2019 and 2024. Data on patient demographics, tumour characteristics, and histopathological findings were analyzed using univariate and multivariate models to identify predictors of residual disease. Results: A residual tumour was detected in 66 of 135 patients (48.9%). In the remaining 69 cases (51.1%), no residual disease was found, indicating that re-excision may have been unnecessary. Multifocality (p < 0.01), lymphovascular invasion (LVI) (p < 0.05), and involvement of ≥2 margins (p < 0.05) were independently associated with the residual tumour. Patients with unifocal disease, absence of LVI, and a single positive margin had a significantly lower risk of residual disease. Conclusions: Over half of re-excisions performed for positive margins may be avoidable. A risk-adapted approach incorporating tumour focality, LVI status, and margin involvement can help identify patients for whom secondary surgery may offer limited benefits. These findings support a more individualized strategy to margin management in BCS aimed at reducing overtreatment without compromising oncologic safety.Keywords
This publication has 37 references indexed in Scilit:
- Positive margins after breast-conserving surgery: is it possible to hang up the scalpel in the era of precision medicine?Updates in Surgery, 2025
- Local Recurrence and Survival Outcomes of Multifocal/Multicentric Breast Cancer After Breast Conserving Therapy: A systematic Review and Meta-AnalysisClinical Breast Cancer, 2024
- EUSOMA quality indicators for non-metastatic breast cancer: An updateEuropean Journal of Cancer, 2023
- Focally positive margins in breast conserving surgery: Predictors, residual disease, and local recurrenceEuropean Journal of Surgical Oncology, 2017
- Extent of Margin Involvement, Lymphovascular Invasion, and Extensive Intraductal Component Predict for Residual Disease After Wide Local Excision for Breast CancerClinical Breast Cancer, 2015
- Positive or close margins in breast conserving surgery: Is re-excision always necessary?European Journal of Surgical Oncology, 2012
- Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapyEuropean Journal of Cancer, 2010
- Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancerThe Breast, 2009
- Residual disease after re‐excision lumpectomy for close marginsJournal of Surgical Oncology, 2008
- The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breastCancer, 2002